Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer Who F
- This topic has 0 replies, 1 voice, and was last updated 8 years, 6 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer Who Failed Gemcitabine-based Combination Chemotherapy.
Not open yet, starts December 2015.
https://clinicaltrials.gov/ct2/show/NCT02579616
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.